Compare RVYL & BFRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RVYL | BFRI |
|---|---|---|
| Founded | 2007 | 1997 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Professional Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.3M | 8.4M |
| IPO Year | N/A | 2021 |
| Metric | RVYL | BFRI |
|---|---|---|
| Price | $5.42 | $0.77 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | N/A | ★ $2.75 |
| AVG Volume (30 Days) | 58.6K | ★ 398.7K |
| Earning Date | 11-14-2025 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $48,858,000.00 | $37,164,000.00 |
| Revenue This Year | N/A | $9.70 |
| Revenue Next Year | $297.49 | $10.97 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 29.50 | 5.11 |
| 52 Week Low | $4.50 | $0.54 |
| 52 Week High | $81.55 | $1.87 |
| Indicator | RVYL | BFRI |
|---|---|---|
| Relative Strength Index (RSI) | 86.89 | 51.32 |
| Support Level | $4.50 | $0.57 |
| Resistance Level | $6.10 | $0.85 |
| Average True Range (ATR) | 0.27 | 0.07 |
| MACD | 0.62 | 0.01 |
| Stochastic Oscillator | 89.26 | 75.93 |
Ryvyl Inc is a technology company that develops, markets and sells blockchain-based payment solutions, which offers improvements to the payment solutions marketplace. Its focus is developing and monetizing disruptive blockchain-based applications, integrated within an end-to-end suite of financial products, capable of supporting a multitude of industries. Its proprietary, blockchain-based systems are designed to facilitate, record, and store a limitless volume of tokenized assets, representing cash or data, on a secured immutable blockchain-based ledger. It has two reportable segments North America and International. It generates the majority of its revenue from North America.
Biofrontera Inc is a United States-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy. The Company's licensed products, which include Ameluz as well as the BF-RhodoLED and RhodoLED XL lamps (together, the RhodoLED Lamps), are used for the treatment of actinic keratoses (AKs), which are pre-cancerous skin lesions.